Skip to content

CORMEDIX INC.: 10-K filed 2017-03-16

What CORMEDIX INC. reported in its annual report filed 2017-03-16 (fiscal FY 2016): 35 published measures, 166 facts as tagged in accession 0001654954-17-002094.

This filing

Form
10-K (annual report)
Filed
2017-03-16
Fiscal period
fiscal FY 2016
Accession
0001654954-17-002094 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All CORMEDIX INC. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2016-12-3121,906,386USD
At 2015-12-3137,101,729USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2016-12-314,091,860USD
At 2015-12-313,090,241USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2016-12-3117,814,526USD
At 2015-12-3134,011,488USD
At 2014-12-313,634,472USD
At 2013-12-31-4,022,343USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2016-12-318,064,490USD
At 2015-12-3111,817,418USD
At 2014-12-314,339,540USD
At 2013-12-312,373,893USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2016-10-01 to 2016-12-31-6,399USD92
2016-01-01 to 2016-12-31-24,643,627USD366
2016-07-01 to 2016-09-30-9,126USD92
2016-04-01 to 2016-06-30-4,887USD91
2016-01-01 to 2016-03-31-4,231USD91
2015-10-01 to 2015-12-31-3,866USD92
2015-01-01 to 2015-12-31-18,187,529USD365
2015-07-01 to 2015-09-30-4,688USD92
2015-04-01 to 2015-06-30-4,135USD91
2015-01-01 to 2015-03-31-5,498USD90
2014-01-01 to 2014-12-31-20,453,427USD365

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2016-01-01 to 2016-12-31-22,265,395USD366
2015-01-01 to 2015-12-31-12,526,898USD365
2014-01-01 to 2014-12-31-6,320,819USD365

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

PeriodValueUnitDays
2016-01-01 to 2016-12-3158,723USD366
2015-01-01 to 2015-12-3115,446USD365
2014-01-01 to 2014-12-3125,402USD365

Revenue

Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.

PeriodValueUnitDays
2016-10-01 to 2016-12-31121USD92
2016-01-01 to 2016-12-31224,105USD366
2016-07-01 to 2016-09-3044USD92
2016-04-01 to 2016-06-3016USD91
2016-01-01 to 2016-03-3141USD91
2015-10-01 to 2015-12-3123USD92
2015-01-01 to 2015-12-31210,130USD365
2015-07-01 to 2015-09-3036USD92
2015-04-01 to 2015-06-30120USD91
2015-01-01 to 2015-03-3131USD90
2014-01-01 to 2014-12-31189,274USD365

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2016-01-01 to 2016-12-317,092,452USD366
2015-01-01 to 2015-12-3143,629,494USD365
2014-01-01 to 2014-12-318,357,916USD365

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

PeriodValueUnitDays
2016-01-01 to 2016-12-3111,419,770USD366
2015-01-01 to 2015-12-31-23,608,071USD365
2014-01-01 to 2014-12-31-25,402USD365

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2016-12-31-119,164,952USD
At 2015-12-31-94,391,595USD

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2016-12-3169,695USD
At 2015-12-3137,866USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

PeriodValueUnitDays
2016-01-01 to 2016-12-311,335,157USD366
2015-01-01 to 2015-12-313,225,659USD365
2014-01-01 to 2014-12-312,168,303USD365

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2016-10-01 to 2016-12-31-6,429USD92
2016-01-01 to 2016-12-31-24,760,918USD366
2016-07-01 to 2016-09-30-9,158USD92
2016-04-01 to 2016-06-30-4,912USD91
2016-01-01 to 2016-03-31-4,261USD91
2015-10-01 to 2015-12-31-3,893USD92
2015-01-01 to 2015-12-31-16,653,971USD365
2015-07-01 to 2015-09-30-4,712USD92
2015-04-01 to 2015-06-30-4,135USD91
2015-01-01 to 2015-03-31-3,914USD90
2014-01-01 to 2014-12-31-8,902,120USD365

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2016-12-3121,831,691USD
At 2015-12-3137,058,863USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

PeriodValueUnitDays
2016-01-01 to 2016-12-311,311USD366
2015-01-01 to 2015-12-313,964USD365
2014-01-01 to 2014-12-312,087USD365

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2016-12-314,091,860USD
At 2015-12-313,061,363USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

PeriodValueUnitDays
At 2016-12-311,645,298USD
At 2015-12-311,709,397USD

Net current accounts receivable

Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.

PeriodValueUnitDays
At 2016-12-3112,014USD
At 2015-12-31315,771USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2016-01-01 to 2016-12-3124,618,350USD366
2015-01-01 to 2015-12-3116,545,383USD365
2014-01-01 to 2014-12-318,645,595USD365

Net inventory

Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.

PeriodValueUnitDays
At 2016-12-31166,733USD
At 2015-12-31376,569USD

Gross profit

Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.

PeriodValueUnitDays
2016-10-01 to 2016-12-3136USD92
2016-01-01 to 2016-12-31-142,568USD366
2016-07-01 to 2016-09-300USD92
2016-04-01 to 2016-06-30-171USD91
2016-01-01 to 2016-03-31-9USD91
2015-10-01 to 2015-12-31-141USD92
2015-01-01 to 2015-12-31-108,588USD365
2015-07-01 to 2015-09-301USD92
2015-04-01 to 2015-06-3018USD91
2015-01-01 to 2015-03-3114USD90
2014-01-01 to 2014-12-31-256,525USD365

Cost of revenue

Costs attributed to goods produced and sold and services provided during the period. This is not the sum of every operating expense.

PeriodValueUnitDays
2016-10-01 to 2016-12-31-85USD92
2016-01-01 to 2016-12-31-366,673USD366
2016-07-01 to 2016-09-30-44USD92
2016-04-01 to 2016-06-30-187USD91
2016-01-01 to 2016-03-31-50USD91
2015-10-01 to 2015-12-31-164USD92
2015-01-01 to 2015-12-31-318,718USD365
2015-07-01 to 2015-09-30-35USD92
2015-04-01 to 2015-06-30-102USD91
2015-01-01 to 2015-03-31-17USD90
2014-01-01 to 2014-12-31-445,799USD365

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

PeriodValueUnitDays
2016-10-01 to 2016-12-314,032USD92
2016-01-01 to 2016-12-3115,735,300USD366
2016-07-01 to 2016-09-306,840USD92
2016-04-01 to 2016-06-302,773USD91
2016-01-01 to 2016-03-312,089USD91
2015-10-01 to 2015-12-311,485USD92
2015-01-01 to 2015-12-316,281,823USD365
2015-07-01 to 2015-09-301,764USD92
2015-04-01 to 2015-06-301,798USD91
2015-01-01 to 2015-03-311,235USD90
2014-01-01 to 2014-12-311,318,734USD365

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2016-12-3140,432,339shares
At 2015-12-3135,963,348shares

Accumulated other comprehensive income or loss

Cumulative other comprehensive items after tax, such as translation and unrealized hedging or securities effects. These amounts have not passed through net income.

PeriodValueUnitDays
At 2016-12-3181,186USD
At 2015-12-3162,130USD

Accrued current liabilities

Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.

PeriodValueUnitDays
At 2016-12-312,342,352USD
At 2015-12-311,221,557USD

Prepaid expenses and other current assets

Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.

PeriodValueUnitDays
At 2016-12-31372,057USD
At 2015-12-31379,004USD

Comprehensive income or loss

Net income plus other comprehensive income after tax. It includes unrealized items that net income excludes and is not a cash measure.

PeriodValueUnitDays
2016-10-01 to 2016-12-31-6,401USD92
2016-01-01 to 2016-12-31-24,624,571USD366
2016-07-01 to 2016-09-30-9,133USD92
2016-04-01 to 2016-06-30-4,890USD91
2016-01-01 to 2016-03-31-4,200USD91
2015-10-01 to 2015-12-31-3,904USD92
2015-01-01 to 2015-12-31-18,224,371USD365
2015-07-01 to 2015-09-30-4,681USD92
2015-04-01 to 2015-06-30-4,144USD91
2015-01-01 to 2015-03-31-5,495USD90
2014-01-01 to 2014-12-31-20,345,132USD365

Net income available to common stockholders

Net income after preferred dividends and similar adjustments, the numerator for basic earnings per share. It can be lower than reported net income.

PeriodValueUnitDays
2016-10-01 to 2016-12-31-6,429USD92
2016-01-01 to 2016-12-31-24,643,627USD366
2016-07-01 to 2016-09-30-9,126USD92
2016-04-01 to 2016-06-30-4,887USD91
2016-01-01 to 2016-03-31-4,231USD91
2015-10-01 to 2015-12-31-3,866USD92
2015-01-01 to 2015-12-31-18,220,650USD365
2015-07-01 to 2015-09-30-4,688USD92
2015-04-01 to 2015-06-30-4,135USD91
2015-01-01 to 2015-03-31-5,498USD90
2014-01-01 to 2014-12-31-20,536,326USD365

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

PeriodValueUnitDays
2016-10-01 to 2016-12-312,433USD92
2016-01-01 to 2016-12-318,883,050USD366
2016-07-01 to 2016-09-302,318USD92
2016-04-01 to 2016-06-301,968USD91
2016-01-01 to 2016-03-312,163USD91
2015-10-01 to 2015-12-312,267USD92
2015-01-01 to 2015-12-3110,263,560USD365
2015-07-01 to 2015-09-302,949USD92
2015-04-01 to 2015-06-302,355USD91
2015-01-01 to 2015-03-312,693USD90
2014-01-01 to 2014-12-317,326,861USD365

Depreciation expense

Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.

PeriodValueUnitDays
2016-01-01 to 2016-12-3125,596USD366
2015-01-01 to 2015-12-3115,076USD365
2014-01-01 to 2014-12-3115,074USD365

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

PeriodValueUnitDays
2016-01-01 to 2016-12-31-307,774USD366
2015-01-01 to 2015-12-31248,186USD365
2014-01-01 to 2014-12-3185,412USD365

Change in inventories

The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.

PeriodValueUnitDays
2016-01-01 to 2016-12-31-79,836USD366
2015-01-01 to 2015-12-3138,540USD365
2014-01-01 to 2014-12-31558,008USD365

Change in accounts payable

The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.

PeriodValueUnitDays
2016-01-01 to 2016-12-31-63,586USD366
2015-01-01 to 2015-12-31825,105USD365
2014-01-01 to 2014-12-318,055USD365

Inspect the source

Entity
CORMEDIX INC. / CIK 0001410098
Captured
2026-09-20T08:01:45.168Z
SEC response SHA-256
b75757faacc84388fbe591a3ec2593969ffefe3c9ea86056a188a6fcb0c2f8bb

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001410098.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))